Log in to save to my catalogue

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicen...

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c12cfa8c47e64d11888bfe3b6eec7303

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial

About this item

Full title

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial

Publisher

England: John Wiley & Sons, Inc

Journal title

ESC Heart Failure, 2021-08, Vol.8 (4), p.3339-3347

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly being used in circulatory failure. The main indications are cardiogenic shock, post‐cardiotomy cardiac failure, and refractory cardiac arrest. However, VA‐ECMO weaning is particularly challenging, and weaning failure is reported to be as high as 50%, with increased r...

Alternative Titles

Full title

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c12cfa8c47e64d11888bfe3b6eec7303

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c12cfa8c47e64d11888bfe3b6eec7303

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.13427

How to access this item